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Abstract. 
 
Calpain 3 is known as the skeletal muscle–
 
speciﬁc member of the calpains, a family of intracellu-
lar nonlysosomal cysteine proteases. It was previously
shown that defects in the human calpain 3 gene are re-
sponsible for limb girdle muscular dystrophy type 2A
(LGMD2A), an inherited disease affecting predomi-
nantly the proximal limb muscles. To better understand
the function of calpain 3 and the pathophysiological
mechanisms of LGMD2A and also to develop an ade-
quate model for therapy research, we generated 
 
capn3
 
-
deﬁcient mice by gene targeting. 
 
capn3
 
-deﬁcient mice
are fully fertile and viable. Allele transmission in inter-
cross progeny demonstrated a statistically signiﬁcant
departure from Mendel’s law. 
 
capn3
 
-deﬁcient mice
show a mild progressive muscular dystrophy that af-
fects a speciﬁc group of muscles. The age of appearance
of myopathic features varies with the genetic back-
ground, suggesting the involvement of modiﬁer genes.
Affected muscles manifest a similar apoptosis-associ-
ated perturbation of the I
 
k
 
B
 
a
 
/nuclear factor 
 
k
 
B path-
way as seen in LGMD2A patients. In addition, Evans
blue staining of muscle ﬁbers reveals that the patholog-
ical process due to calpain 3 deﬁciency is associated
with membrane alterations.
Key words: calpain • apoptosis • muscular dystro-
phies • I
 
k
 
B
 
a
 
/NF-
 
k
 
B pathway • knockout mice
 
Introduction
 
Calpains are calcium-dependent intracellular nonlysoso-
mal proteases. The first characterized vertebrate calpains
were the ubiquitous 
 
m
 
 and m-calpains (Yoshimura et al.,
1983). Identification of new members of the calpain fam-
ily, expressed at various levels in different tissues, revealed
the complexity of this family. In mammals, at least 11 dif-
ferent calpain genes have now been identified (Sorimachi
et al., 1997; Dear and Boehm, 1999). Among them,
 
CAPN3
 
, the calpain 3 gene, is expressed predominantly as
a 94-kD protein in adult skeletal muscles (Sorimachi et al.,
1989). It is, at present, the only member of the human
calpain family whose deficiency is associated with a de-
fined phenotype, as it was shown that mutations in
CAPN3 lead to limb girdle muscular dystrophy type 2A
(LGMD2A)
 
1
 
 (Richard et al., 1995). Atrophy and weak-
ness of the proximal muscles of the limbs, especially those
of posterior compartments, characterize this pathology
(Fardeau et al., 1996).
Physiological functions of the calpains are still broadly
unknown but, as proteases, they may regulate important
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factor; RT, reverse transcriptase; tk, thymidine kinase; TUNEL, terminal
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cellular functions. Sorimachi et al. (1993) showed that
calpain 3 undergoes an autolytic degradation immediately
after translation, at least when expressed in COS-7 cells. It
was also shown that when wild-type calpain 3 is expressed
in COS-7 cells, the 230-kD intrinsic fodrin subunit is pro-
teolyzed, yielding a 150-kD fragment (Ono et al., 1998).
Calpain 3 may exert a selective action in the nucleus as it
contains within its amino acid sequence a nuclear translo-
cation signal (Sorimachi et al., 1989) and could also be de-
tected in myonuclei (Baghdiguian et al., 1999). Increase in
apoptosis and change in the localization profile of nuclear
factor (NF)-
 
k
 
B, a transcription factor driving the tran-
scription of several survival genes and of its inhibitor,
I
 
k
 
B
 
a
 
, were found in biopsies from LGMD2A patients
(Baghdiguian et al., 1999). In spite of these data, it is still
unclear how a deficiency in this proteolytic enzyme could
lead to a dystrophic process. It is worth mentioning
that the majority of the other muscular dystrophies are
caused by mutations in genes encoding structural proteins.
This stands in contrast to the proteolytic deficiency in
LGMD2A.
To better understand the function of calpain 3 and the
pathophysiological mechanisms of LGMD2A and also to
develop an adequate model for therapy research, we gen-
erated 
 
capn3
 
-deficient mice by gene targeting. Although
these mice seem indistinguishable from normal mice, ex-
amination of their skeletal muscles demonstrates clearly
that they suffer from muscular dystrophy. The data ob-
tained in these mice suggest that presence of the pro-
teolytic activity of calpain 3 is necessary to protect myo-
cytes from a death signal and show that its absence is
associated with membrane alterations.
 
Materials and Methods
 
Gene Targeting
 
Screening of a mouse embryonic stem (ES) cell (strain 129Sv) library us-
ing two radiolabeled cDNA probes corresponding to exons 2–4 and exons
15–24, respectively, of the calpain 3 gene led to the identification of 13 re-
combinant 
 
l
 
 phage clones. One of them (B1) was characterized by restric-
tion mapping and limited sequencing. It was then used to construct a
gene-targeting vector in a neomycin resistance (neoR) gene–containing
plasmid (pD383; a gift of P. Kastner, IGBMG, Illkirch, France). A 6-kb
HindIII-EcoRI fragment containing the distal part of intron 1 was in-
serted between the HindIII and EcoRI sites of a plasmid (p572GTI-2) car-
rying the herpes virus thymidine kinase (tk) gene and a 2.1-kb KpnI frag-
ment containing exons 4 and 5 was inserted into the KpnI site of pD383.
In a second step, the SalI fragment of the latter plasmid covering the KpnI
fragment and tk gene was inserted at the SalI site of the p572GTI-2.
Thereby, the targeting vector deletes the genomic sequence correspond-
ing to exons 2 and 3 of 
 
capn3
 
. This 12-kb vector was linearized at the NotI
site of the multiple cloning site, and 20 
 
m
 
g of DNA was electroporated
into 10
 
7
 
 ES cells of 129Sv origin. 358 stable transfected cells were isolated
after selection in medium supplemented first with 350 
 
m
 
g/ml of G418 and
then with 2 
 
m
 
M gancyclovir. DNA was isolated from the various cell lines
by phenol-chloroform extraction. To detect homologous recombination
events at the 
 
capn3
 
 locus, 100 ng of this DNA was used as template in a
long-range PCR assay, using neoR-specific primers and external primers
located 5
 
9
 
 and 3
 
9
 
 of the construct (see Fig. 1 a). Sequences of the primers
are as follows: in 5
 
9
 
 upper primer (5
 
9
 
.a, GACCCACTTCTCCTCAATC-
CATGCA) and lower primer (Neo.1, CTTCACATACACCTTGTCTC-
CGACG); in 3
 
9
 
 upper primer (Neo.2 TACTTCCATTTGTCACGTCCTG-
CAC) lower primer (3
 
9
 
.m, ACCCCAGACTACTATTCCCAAAGCA).
ES cells from one of the three correctly targeted clones (clone 32, 64, and
137) were injected into blastocysts derived from the C57BL/6 mice. Blasto-
cysts were transferred to pseudopregnant foster mothers, and chimeric off-
springs were identified by the presence of agouti hair. Chimeric males
 
were mated to C57BL/6 females to obtain ES-derived offsprings that were
analyzed by PCR on tail DNA to identify the heterozygous mice. The
combination of gene-specific primers used for this purpose was for the
neoR gene, Neo.3 (AGACTGCCTTGGGAAAAGCG)/ex4.m (ACCA-
CATCTACCCAGTCTCC) and for 
 
capn3
 
, ex2.a (GAGCCAACAG-
GACTCACATCT)/in2.m (CGCCTCTGCCCAAAAGACT) or ex3.a
(CCTGCCTGACCCTGAATGAG)/ex3.m (TGGAAGTGGAAGATC-
CCTGC). DNA amplification was carried out for 35 cycles at 53
 
8
 
C for
ex3.a/ex3.m or at 61
 
8
 
C for Neo.3/ex4.m and ex2.a/in2.m. Heterozygous
mice were mated inter se to generate homozygous mutant mice.
 
Statistical Analysis of Transmission Ratio Distortion
 
The number of animals of each genotype expected according to Mendel’s
law was calculated. The significant departure of observed values com-
pared with expected values was estimated using a 
 
x
 
2
 
 test.
 
RNA and Protein Analysis
 
Expression of the calpain 3 gene
 
 
 
was investigated by a real-time quantita-
tive reverse transcriptase (RT)-PCR method using TaqMan probes (Perkin-
Elmer) (Heid et al., 1996) as described (Herasse et al., 1999). Investiga-
tion of autolysis, proteolysis of in vitro substrates, and titin-binding
capacity was performed as described (Herasse et al., 1999). The following
primary antibodies were used: anti-p94 (Baghdiguian et al., 1999) and an-
tifodrin (Ono et al., 1998).
 
Determination of Serum Level of Creatine Kinase
 
Blood was collected from the retroorbital sinus of mice, and the serum
was stored at 
 
2
 
20
 
8
 
C until measurements were taken. Quantitative kinetic
determination of creatine kinase (CK) activity in serum of control and
 
capn3
 
2/2
 
 mice was measured by Vetfrance.
 
Analysis of Muscle Specimen
 
Four or five affected animals were examined at each age for each of the
two genetic backgrounds. Striated muscles were removed from the ani-
mals, frozen in isopentane cooled in liquid nitrogen, and kept at 
 
2
 
80
 
8
 
C
until use. Longitudinal and transverse 7-
 
m
 
m sections were made and pro-
cessed for hematoxilin and eosin (H&E) histological staining or fluores-
cence labeling. Nuclear DNA fragmentation visualization and indirect im-
munofluorescence confocal microscopy were performed as described
(Baghdiguian et al., 1999). The following primary antibodies were used:
anti-I
 
k
 
B
 
a
 
 (FL, sc-847; Santa Cruz Biotechnology, Inc.) and anti–NF-
 
k
 
B
(C20, sc-372; Santa Cruz Biotechnology, Inc.). The number of centronu-
cleated fibers was counted by examination of the H&E-stained sections
(three different sections for each animal) under a light microscope and the
total number of fibers present in the section was counted on digitized im-
ages.
 
Evans Blue Dye Staining
 
Intraperitoneal injection of Evans blue (EB) dye (0.5 mg/10 g of body
weight; Sigma-Aldrich) was performed on 6-mo-old mice of 129Sv back-
ground (
 
n
 
 5 
 
4 for each genotype). Mice were killed 12 h after injection.
Muscles were examined for blue coloration indicating dye uptake. Muscle
cryosections were fixed in acetone cooled at 
 
2
 
20
 
8
 
C, rinsed in PBS, and
mounted with Vectashield medium (Vector Laboratories). Sections were
examined under a Leica fluorescence or a ZEISS confocal microscope.
Sections were also stained for terminal deoxynucleotidyl transferase-
mediated dUTP nick end labeling (TUNEL) positivity and propidium iodide.
 
Results and Discussion
 
Generation of capn3
 
2/2
 
 Mice
 
In a previous study, Ono et al. (1998) showed in vitro that
impairment of calpain 3–mediated proteolysis was a com-
mon feature of several LGMD2A mutations. Therefore,
we targeted the proteolytic function for gene disrup-
tion using homologous recombination to produce calpain
3–deficient mice. Since exon 3 encodes the critical cysteine
participating in the proteolytic site (Sorimachi et al., 1989), 
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Figure 1. Gene targeting of
mice. (a) Restriction map of
the targeting construct, the
wild-type  capn3 locus, and the
targeted locus. A fragment
containing exons 2 and 3 en-
compassing C129, the cysteine
participating to the catalytic
site, was deleted and replaced
by a neoR cassette. The herpes
simplex virus tk (TK) cassette
was added 59 to the targeting
vector for positive–negative se-
lection. H, E, and K indicate
HindIII, EcoRI, and KpnI, re-
spectively. (b) Double-resis-
tant ES cell clones were geno-
typed by long-range PCR using
two primer pairs (59.a/Neo.1
and Neo.2/39.m). Primer sites
are shown in panel a. The 6-
and 2.1-kb PCR products are
indicative of correct homolo-
gous recombination events in
the 59 and 39 neoR flanking re-
gions, respectively. (c) Geno-
type analysis of progeny from a
heterozygote intercross. PCR
analysis of tail DNA isolated
from 3-wk-old mice was per-
formed using the PCR primer
pairs Neo.3/ex4.m (top) and
ex3.a/ex3.m (bottom). Normal
mice DNA (1/1) gave an am-
plification product only with
exon 3 primer pairs; capn32/2
mice DNA (2/2), only with
neo primer pairs; and capn31/2
mice DNA gave amplification
products with both sets of
primers. (d) Quantitative RT-
PCR analysis of calpain 3 mes-
senger level, expressed relative
to wild-type mice, in RNA ex-
tracted from muscle. The anal-
ysis was performed according
to TaqMan chemistry using
primer pairs located in exon 1.
Level of TFIID mRNA was
used to normalize the results
across different samples. The
bars indicate the mean value 6
the minimum or maximum. (e)
Western blot analysis. A
calpain 3–specific polyclonal
antibody directed against the
IS2 region of calpain 3 was used to detect calpain 3 expression in the muscle of wild-type (1/1) and capn32/2 (2/2) mice. A Western
blot using a calpain 2–specific polyclonal antibody was used as a control. Zinc staining was used to ascertain equivalent loading. (f) West-
ern blot analyses were performed on lysates of transfected COS-7 cells to visualize proteolytic calpain 3 fragments using an antibody
against the IS2-specific region of p94. The constructs used were the vector alone (pSRD) or derived constructs containing, respectively,
the wild-type calpain 3 (p94), the cDNA corresponding to the calpain 3–deficient mice (KO), and a defective cDNA carrying the muta-
tion C129S. White and black arrowheads indicate the full-length and proteolyzed products, respectively. (g) Proteolysis of fodrin was as-
sessed using antibodies specific to the 150-kD a-fodrin fragment. The proteolized fragment was only detected for the wild-type calpain 3.
(h) The titin-binding capacities of the cDNA was monitored in a yeast two-hybrid system, using as bait two different titin clones corre-
sponding to the COOH-terminal (C-ter) region (pCNT-52) and to the region located in the N2A line of the sarcomere (pCNT-N2).
Wild-type (p94), mutant calpain 3 (KO) cDNA, or vector alone (T-[pAS2C-1]) was cotransfected with the titin clones into Saccharomy-
ces cerevisiae CG-1945 strain cells. Binding was visualized as growth on plates without leucine and without tryptophane. Deletion of ex-
ons 2 and 3 does not impair binding to the N2A region of titin but weakens binding to the COOH-terminal region. 
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we constructed a replacement vector in which exons 2 and
3 are substituted by a neoR cassette (Fig. 1 a). After elec-
troporation and selection of G418-resistant ES cell clones
carrying the recombinant allele (Fig. 1 b), chimeric ani-
mals were generated and subsequently mated to obtain
 
capn3
 
1/2
 
 progeny. Mating of heterozygous animals en-
abled the production of 
 
capn3
 
2/2
 
 mice (Fig. 1 c). As the
phenotypic consequences of a natural or introduced muta-
tion could depend on genetic background, appropriate
crosses were undertaken to obtain congenic strains of
129Sv and C57BL/6 backgrounds. The genetic back-
grounds of the examined mice were either of pure 129Sv
or a mixture of C57BL/6 and 129Svter (with a ratio of 3:1
or 7:1), the latter being referenced here as the mix line.
Skeletal muscles of the 
 
capn3
 
2/2
 
 mice showed a dra-
matic decrease of 
 
capn3
 
 mRNA and a complete absence
of calpain 3 protein as verified, respectively, by quantita-
tive RT-PCR (Fig. 1 d) and Western blot analyses (Fig. 1
e). Cloning and sequencing of the recombinant mRNA
produced by 
 
capn3
 
2/2
 
 mice demonstrated that the corre-
sponding protein would carry an in-frame deletion of
amino acids 104–166 as the neoR cassette was spliced out.
In vitro investigation of known biochemical characteris-
tics of the corresponding recombinant calpain 3 protein
showed that autolysis (Fig. 1 f) and proteolysis of fodrin
(Fig. 1 g), an in vitro substrate, were abolished, whereas
titin-binding ability in the N2A region, assayed in a yeast
two-hybrid system, was preserved (Fig. 1 h). Thus, the ef-
fect of the disruption of the mouse 
 
capn3
 
 gene can be re-
lated to the effects of the human mutations, at least with
respect to proteolysis.
 
Inactivation of Calpain 3 Leads to Transmission
Ratio Distortion
 
The distribution of wild-type, heterozygous, and homozy-
gous calpain 3 mutant mice among 250 offsprings of het-
erozygous crosses revealed a statistically significant depar-
ture from Mendelian transmission with, surprisingly, a
ratio in favor of 
 
capn3
 
2/2
 
 pups in both the mix and 129Sv
lines (Table I;
 
 P 
 
, 
 
0.01). Although this observation dem-
onstrates that inactivation of calpain 3 does not lead to le-
thality in utero or shortly after birth, it also suggests that
calpain 3–null alleles tend to be transmitted preferentially.
Litter sizes are normal, suggesting that the underlying phe-
nomenon acts before development, probably during game-
togenesis or fertilization. This transmission ratio distortion
is likely to be due to the impairment of calpain 3, as the ge-
nomes of the 
 
1
 
/
 
1
 
 and 
 
2/2
 
 mice in the 129Sv line differ
only by the introduced mutation. Existence of transmis-
sion ratio distortion, if validated on human populations,
may have direct implications for the study of LGMD2A,
especially for genetic counseling. Furthermore, under-
standing the mechanism underlying this phenomenon may
lead to new insights on the function of calpain 3, as it sug-
gests a role in the germ line. Analyzing mRNA from testis
and ovary, transcripts for differnent calpain 3 isoforms
were detected, although at a low level, compared with
muscle (data not shown). These observations further in-
crease the complexity of calpain 3 expression, as it is now
known that alternative promoter or splicing gives rise to
several calpain 3 isoforms in a large variety of tissues such
as smooth and cardiac muscles, brain, thymus, leukocyte,
and eye tissues (Ma et al., 1998; Herasse et al., 1999).
 
capn3
 
2/2
 
 Mutant Mice Develop a Progressive Mild 
Muscular Dystrophy
 
capn3
 
2/2
 
 mice exhibit a postnatal appearance similar to
that of wild-type littermates and develop normal behav-
ioral activity. They are fertile and have been kept alive for
 
.
 
1.5 yr with no increase in spontaneous deaths.
Increase in serum CK level is a criterion used to ascer-
tain muscle fiber degeneration. Hence, it was evaluated in
animals from both genotypes (
 
2/2
 
 and 
 
1
 
/
 
1
 
) of 129Sv ge-
netic background. Animals were grouped into age classes
(2–3, 3–4, and 5–7 mo of age). Fig. 2 shows that the differ-
ence in mean CK levels between the two genotypes in-
creases with age. It should be noted, however, that this pa-
rameter cannot be used as a test to distinguish between 
 
2/2
 
and 
 
1
 
/
 
1
 
 due to the high variability of individual levels.
 
Table I. The Distribution of Wild-Type, Heterozygous, and 
Homozygous Offsprings of Heterozygous Crosses
 
Genotypes
 
1/1 1/2 2/2
 
Observed 44 128 84
Expected 62.5 125 62.5
 
x
 
2
 
5.48 (
 
P value ,0.02) 0.07 7.40 (P value ,0.01)
Data show observed and expected numbers of animals according to their genotypes at
the capn3 locus.
Figure 2. Serum CK activity. This parameter was evaluated on the
129Sv background. Animals were grouped into three classes accord-
ing to their age. For the 2–3-mo-old animals, n 5 38 for 2/2, n 5 25
for 1/1; for the 3–4-mo-old animals, n 5 68 for 2/2, n 5 6 for the
1/1; and for the 5–7-mo-old animals, n 5 37 for 2/2 and n 5 21 for
1/1. The bars indicate the mean values 6 SD. P , 0.09 at 2–3 mo of
age, P , 0.03 at 3–5 mo of age, and P , 0.002 at 6 mo of age.Richard et al. Loss of Calpain 3 Proteolytic Activity in Mice 1587
The pathological aspect of H&E-stained frozen cross
sections of various muscles was evaluated in calpain
3–deficient mice from the ages of 8 wk to 19 mo and com-
pared with those of age-matched normal mice. Pathologi-
cal changes characteristic of muscular dystrophy such as
centronucleation, area of necrosis/regeneration, splitting
of fibers, and foci of mononuclear cell infiltrates can be
seen in both genetic backgrounds (Fig. 3). It should be
noted that, in most cases, fibers with internal nuclei are
clustered. Alterations increase with age, and the level of
abnormality is variable depending on the muscle exam-
ined. Considering the combined effect of all alterations,
psoas, soleus, and deltoid are the most affected muscles;
tibialis anterior and biceps are affected but to a lower ex-
tent, whereas the quadriceps, gastrocnemius, and triceps
brachii do not seem to be substantially affected.
Figure 3. Histologic analysis of capn3-deficient mice. H&E-stained transverse muscle cryosections (7 mm) from mice of 129Sv genetic
background. (a–d) 2-mo-old mice; (e–l) 6-mo-old mice. Dystrophic changes are evident in psoas (a and e), soleus (b and f), deltoid (c
and g), and tibialis anterior (d and h), whereas quadriceps (i), gastrocnemius (j), and triceps (k) present a normal aspect. Diaphragm in
l presents very slight abnormalities. The main features encountered are fibers with internal nuclei (b–f, and h) or area of infiltration of
mononuclear cells (a and g). A cluster of small regenerating fibers can be seen in e. Bars, 50 mm.The Journal of Cell Biology, Volume 151, 2000 1588
The distribution of the impairment is the same on both
genetic backgrounds. However, in the 129Sv congenic line,
signs were already evident at 2 mo of age, whereas in
6-mo-old animals of mixed background, only discrete ab-
normalities are seen (Table II). The diaphragm is the only
muscle examined that seems to be similarly affected in
both lines. These observations suggest that the phenotypic
consequences of a mutation in capn3 can be affected by
the presence of a modifier gene(s). The same assumption
can be made in humans, as phenotypic variations have
been reported among siblings carrying identical CAPN3
mutations (Penisson-Besnier et al., 1998).
Apoptosis and the IkBa/NF-kB Pathway
The analysis of muscle biopsies of LGMD2A patients re-
vealed that calpain 3 deficiency is associated with myonu-
clear apoptosis and profound perturbation in the expression
of the transcription factor NF-kB and of its inhibitor IkBa
(Zabel et al., 1993; Baldwin, 1996; Baghdiguian et al., 1999).
Therefore, we examined whether the same events can be
seen in calpain 3–deficient mice. A TUNEL assay and im-
munostaining using polyclonal antibodies against NF-
kBp65 and IkBa were performed on histologically affected
muscles. The results demonstrate the presence of myofibers
presenting TUNEL-positive nuclei associated with nuclear
localization of IkBa (Fig. 4 a). With respect to NF-kB stain-
ing, half of the calpain 3–deficient muscle sections examined
present a subsarcolemmal localization (Fig. 4 b), whereas
the other half present a normal pattern, that is labeling of
some myonuclei. The coexistence of these two patterns sug-
gests that the deficiency in calpain 3 is not sufficient to lead
to an abnormal localization of NF-kB and that another ele-
ment (e.g., a death signal) should intervene. In the absence
of such a signal, the intervention of NF-kB may not be nec-
essary and, therefore, a calpain 3–deficient muscle would
not differ from a normal muscle with respect to the NF-kB/
IkBa expression. The idea of the necessity of a signal is
compatible with the observation that the pathological fea-
tures present in the muscle sections of the calpain 3–defi-
cient mice are often clustered in particular areas.
Table II. Distribution of Centronucleation with Respect to Genetic Background and Muscle Type in capn32/2 Mice
6-mo-old C57BL/6/129Sv (n 52) 9-mo-old C57BL/6/129Sv (n 55) 2-mo-old 129Sv (n 55) 6-mo-old 129Sv (n 54)
Psoas ,1.0 5.8 (3.0–10.0) 3.8 (,1.0–6.5) 7.3 (3.0–10)
Soleus ,1.0 8.2 (4.0–11.0) 2.0 (,1.0–6.0) 16.0 (2.0–28)
Deltoid ø3.0 4.2 (1.5–8.0) 1.2 (,1–1.9) 4.0 (3.0–5.5)
Extensor digitorum longus 
plus tibialis anterior
,1.0 3.9 (1.5–7.5) 1.9 (,1.0–2.0) 4.2 (4.0–6.0)
Biceps ø1.5 ø2.0 1 (,1.0–2.0) 2.5 (2.0–5.5)
Quadriceps ,1.0 1.5 (1.0– 3.0) ,1.0 ,1.0 (,1.0–2.0)
Gastrocnemius 2.0 1 (,1.0–2.5) ,1.0 ,1.0 (,1.0–2.0)
Triceps ,1.0 ,1.0 ,1.0 ,1.0 (,1.0–1.5)
Mean ratio of fibers with internal nuclei among fibers of n mice on C57BL/6/129Sv background (at 6 and 9 mo of age) and on 129Sv background (at 2 and 6 mo of age). The lowest
and highest levels are indicated in parentheses. The levels of centronucleation were examined in the same muscles of wild-type mice of the same genetic backgrounds as presented
here and were never found to be .1%.
Figure 4. Apoptosis and im-
munolocalization of IkBa and
NF-kB in muscles of calpain
3–deficient mice. (a) A longi-
tudinal muscle section of a
calpain 3–deficient mouse was
triple labeled for apoptosis (green
myonuclei superimposed over
the phase–contrast field), IkBa
(red), and chromatin (DAPI,
right). Note that TUNEL-posi-
tive myonuclei were always
IkBa-positive (arrowheads).
(b) Subsarcolemmal localization of NF-kB (blue fluorescence, left). Note that in this calpain 3–deficient tissue, NF-kB was not found
concentrated in the myonuclei (stained with DAPI, right, arrowheads). (c) As a control, NF-kB (blue fluorescence) was normally found
concentrated in some myonuclei of wild-type mice (arrowheads). The DAPI fields were recorded with a CCD camera mounted on an
additional port of the confocal microscope. For a, 10 mm corresponds to 72.3 mm, and for b and c, 10 mm corresponds to 57 mm.Richard et al. Loss of Calpain 3 Proteolytic Activity in Mice 1589
Sarcolemmal Integrity, Apoptosis, and
Calpain 3 Deficiency
Loss of sarcolemmal integrity is a characteristic feature of
several muscular dystrophies (Petrof et al., 1993; Matsuda
et al., 1995; Straub et al., 1997). It was not clear if a defi-
ciency in calpain 3 could also lead to sarcolemmal damage.
No alterations of the gene products known to be involved
in other progressive muscular dystrophies disclosing simi-
lar clinical signs and classified under the term LGMD2
(Roberds et al., 1994; Bönnemann et al., 1995; Lim et al.,
1995; Noguchi et al., 1995; Nigro et al., 1996) were seen in
capn32/2 mice; immunohistochemical investigation of a-,
b-, and g- sarcoglycan and of dystrophin did not reveal any
abnormality (data not shown). These data are consistent
with observations made in humans. To test further if muta-
tion in calpain 3 could result in impairment of membrane
integrity, membrane permeability was assessed by intra-
peritoneal injection of EB dye, a normally impermeant
molecule. Tracer uptake was detected by microscopic in-
spection in a limited number of muscle cells of calpain
3–deficient mice (Fig. 5 a). This observation is a clear
demonstration that membrane alterations exist during the
pathological process induced by calpain 3 deficiency.
TUNEL assays performed on muscle sections revealed
that only EB-stained fibers present apoptotic myonuclei
(Fig. 5 b). A similar observation was reported for mdx
mice (Matsuda et al., 1995). We have shown previously in
LGMD2A patients that apoptotic levels parallel CK lev-
els, i.e., they are highest when CK leaks are highest (Bagh-
diguian et al., 1999). The concordance of apoptotic nuclei
and EB positive cells suggests that elevation of CK level is
presumably associated with loss of the sarcolemmal integ-
rity. It remains unclear whether activation of the apoptotic
cascade is a cause or a consequence of membrane impair-
ment. In support of the former, apoptosis was reported to
be associated, at least in one occurrence, with changes in
permeability of the cell membrane through the effect of
perforin excreted by cytotoxic lymphocytes (Dourmashkin
et al., 1980). Furthermore, in mdx mice, apoptosis occurs
by perforin-mediated cytotoxicity (Spencer et al., 1997).
This suggests that a similar mechanism could also happen
in LGMD2A and that common pathological features
could exist between dystrophin and calpain 3 deficiencies.
On the other hand, if the latter hypothesis is correct, defi-
ciency of calpain 3 could directly lead to membrane dam-
age by an yet unknown mechanism. This could cause ex-
tracellular calcium influx into the cytoplasm eventually
triggering apoptosis.
Conclusion
The selectivity of the muscular impairment, the compati-
bility of the biopsy appearance with a necrosis/regenera-
Figure 5. EB staining of cryosections of calpain 3–deficient muscles reveals apoptosis-associated disruption of sarcolemmal integrity.
Four 6-mo-old animals of each genotype were killed 12 h after being injected with EB dye and biopsied. Regions of EB uptake are seen
as red cytoplasmic staining on fluorescence microscopy. A mean of three EB-positive cells was detected per muscle section of calpain
3–deficient mice. (a) Calpain 3–deficient biceps showing EB staining. No EB uptake is seen in wild-type biceps. (b) Triple labeling for
EB, TUNEL, and propidium iodide (PI) of a muscle section of calpain 3–deficient mouse. From left to right, EB-positive cells (red
pseudocolor), TUNEL-positive myonuclei, propidium iodide–stained nuclei (blue pseudocolor), and a superposition of all stainings
(white arrows and/or green pseudocolor refer to apoptotic nuclei). Bars: (a) 50 mm; (b) 20 mm.The Journal of Cell Biology, Volume 151, 2000 1590
tion pattern, and the preservation of the dystrophin-asso-
ciated complex (data not shown) are elements showing
similarity with the corresponding human disease. In addi-
tion, apoptosis in these mice myonuclei seems to be associ-
ated both with a perturbation of the NF-kB/IkBa pathway
and with an impairment of membrane permeability. The
calpain 3–deficient mice will thus provide a valuable re-
source for further dissection of the molecular events gov-
erning dystrophic changes and apoptosis in muscle as well
as for the development of therapeutic rescue strategies.
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